Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Details Narrative)

v3.8.0.1
Stock-Based Compensation (Details Narrative)
1 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2017
$ / shares
Dec. 14, 2016
Number
$ / shares
shares
Mar. 31, 2016
$ / shares
shares
Mar. 31, 2017
$ / shares
shares
Jul. 31, 2017
USD ($)
shares
Jan. 31, 2017
Jul. 31, 2017
USD ($)
$ / shares
shares
Jul. 31, 2016
USD ($)
$ / shares
shares
Options granted to purchase shares             3,028,536 2,729,250 [1]
Stock option exchange description   Stock options with an exercise price greater than or equal to $3.00, and held by employees, directors, and consultants in continuous service through the termination of the Exchange Offer, were eligible for exchange in the Exchange Offer. An exchange rate of 2 for 1 applied to options priced from $3.00 to $9.99, and an exchange rate of 3 for 1 applied to options priced at $10 or greater. Each new stock option was granted pursuant to OncoSec’s 2011 Stock Incentive Plan, as amended and restated, on the date the Exchange Offer closed and was priced at the market price on that date.            
Purchase price of incentive stock options as a percentage of its fair value             85.00%  
Stock-based compensation expense recognized | $             $ 23,000 $ 16,000
Weighted-average grant date fair value | $ / shares             $ 0.69 $ 3.45
Weighted average period             7 years 110 months 23 days 8 years 11 days
Weighted-average fair value of stock options vested | $ / shares             $ 1.35 $ 5.69
Unrecognized non-cash compensation cost | $         $ 1,400,000   $ 1,400,000  
Share based compensation shares issued              
Common shares outstanding         21,618,194   21,618,194 18,036,263
Number of shares available for issuance         526,637   526,637  
Restricted Stock Units (RSUs) [Member]                
Stock-based compensation expense recognized | $             $ 462,000 $ 184,000
Common shares outstanding         1,100,000   1,100,000 655,000
Research And Development Expense [Member]                
Stock-based compensation expense recognized | $             $ 1,100,000 $ 1,000,000
Research And Development Expense [Member] | Restricted Stock Units (RSUs) [Member]                
Stock-based compensation expense recognized | $             90,000 41,000
General And Administrative Expense [Member]                
Stock-based compensation expense recognized | $             2,500,000 5,100,000
General And Administrative Expense [Member] | Restricted Stock Units (RSUs) [Member]                
Stock-based compensation expense recognized | $             372,000 143,000
Exchange Offer [Member]                
Number of eligible participants | Number   29            
29 Eligible Participants [Member]                
New options   1,070,536            
Shares purchased   2,214,500            
Exchange Rate of 2 for 1 Applied [Member]                
Exercise price per share, low end of the range | $ / shares   $ 3.00            
Exercise price per share, high end of the range | $ / shares   9.99            
Exchange Rate of 3 for 1 Applied [Member]                
Exercise price per share, low end of the range | $ / shares   10            
Employee, Director and Consultants [Member]                
Stock options exercise price | $ / shares   $ 3.00            
Employee, Director and Consultants [Member] | Restricted Stock Units (RSUs) [Member]                
Vesting period 3 years   3 years          
Employee [Member] | Restricted Stock Units (RSUs) [Member]                
Share based compensation shares issued     555,000          
Director [Member] | Restricted Stock Units (RSUs) [Member]                
Share based compensation shares issued     100,000          
Consultants [Member] | Restricted Stock Units (RSUs) [Member]                
Share based compensation shares issued     25,000          
Employees [Member] | Restricted Stock Units (RSUs) [Member]                
Share based compensation shares issued       525,000        
Shares issued, price per share | $ / shares $ 1.34   $ 2.02 $ 1.34        
Employees, Directors and Consultants [Member]                
Stock-based compensation expense recognized | $             $ 3,600,000 $ 6,100,000
Plan2011 [Member]                
Options granted to purchase shares             2,689,250  
Maximum percentage increase in number of share authorized, approved by shareholders             3.00%  
Maximum increase in number of shares authorized             500,000  
Maximum shares granted per fiscal year per individual             500,000  
Plan2011 [Member] | Minimum [Member]                
Provisional percentage of outstanding stock owned by stockholders             10.00%  
Exercise price as a percentage of fair value of common stock             110.00%  
Purchase price of incentive stock options as a percentage of its fair value             100.00%  
Plan2011 [Member] | Employee, Director and Consultants [Member]                
Employee stock purchase program description             The 2011 Plan includes an automatic increase of the number of shares of common stock reserved thereunder on the first business day of each calendar year by the lesser of: (i) 3% of the shares of the Company’s common stock outstanding as of the last day of the immediately preceding calendar year; (ii) 500,000 shares; or, (iii) such lesser number of shares as determined by the Company’s Board of Directors.  
Options granted to purchase shares             4,000,000  
Plan2011 [Member] | Employee [Member]                
Options granted to purchase shares             1,841,037  
Term of stock options             10 years  
Vesting period             3 years  
Exercise price per share, low end of the range | $ / shares             $ 1.11  
Exercise price per share, high end of the range | $ / shares             $ 1.94  
Plan2011 [Member] | Director [Member]                
Options granted to purchase shares             355,416 655,500
Term of stock options             10 years 10 years
Vesting period             1 year 1 year
Exercise price per share, low end of the range | $ / shares             $ 1.29 $ 2.02
Exercise price per share, high end of the range | $ / shares             $ 1.34 $ 5.76
Plan2011 [Member] | Consultants [Member]                
Options granted to purchase shares             832,083 78,000
Term of stock options             3 years  
Exercise price per share, low end of the range | $ / shares             $ 1.29 $ 2.02
Exercise price per share, high end of the range | $ / shares             $ 2.00 $ 5.76
Plan2011 [Member] | Consultants [Member] | Minimum [Member]                
Term of stock options               1 year
Plan2011 [Member] | Consultants [Member] | Maximum [Member]                
Term of stock options               3 years
Plan2011 [Member] | Employees [Member]                
Options granted to purchase shares               1,955,750
Term of stock options               10 years
Vesting period               3 years
Exercise price per share, low end of the range | $ / shares               $ 1.64
Exercise price per share, high end of the range | $ / shares               $ 6.21
2015 ESPP [Member]                
Purchase price of incentive stock options as a percentage of its fair value             85.00%  
Stock-based compensation expense recognized | $             $ 27,000  
Stock issued during period, shares, employee stock purchase plans             500,000  
Discount from market price, offering date             15.00%  
Fair market value of unvested shares, percentage             15.00%  
Risk-free interest rate         0.40% 0.65%    
Forfeiture percentage         0.00% 0.00%    
Volatility rate         96.91% 132.68%    
Expected term of volatility         6 months 6 months    
Dividend rate         0.00% 0.00%    
2015 ESPP [Member] | First Offering Period [Member] | July 31, 2016 [Member]                
Shares purchased             17,789  
2015 ESPP [Member] | Second Offering Period [Member] | January 31, 2017 [Member]                
Shares purchased             18,631  
2015 ESPP [Member] | Third Offering Period [Member] | July 31, 2017 [Member]                
Shares purchased             21,646  
ESPP [Member]                
Number of shares available for issuance         463,580   463,580  
[1] Recast to reflect the 1-for-20 reverse stock split effected May 2015